Clinical Nutrition Market - Global Outlook & Forecast 2024-2029

List of Tables

The global clinical nutrition market is expected to grow at a CAGR of 7.35% from 2023 to 2029.

MARKET TRENDS & DRIVERS

Rise of Targeted & Personalized Nutrition

Personalization nutrition is a rapidly growing field in the clinical nutrition market that includes science-based assessments to deliver individuals with targeted nutritional products or advice. Medical professionals and patients are moving away from a one-size-fits-all approach to value their nutritional goals. Personalized clinical nutrition or precision clinical nutrition, which utilizes nutritional products, lifestyle, and individual biomarkers to craft healthy nutritional suggestions more relevant to the individual, continues to gain popularity. Personalization and a targeted solution came up with highly specific and fully developed formulas that fulfill the needs of individual patients/people for nutritional support. Innovation in targeted and personalized solutions has grown and evolved rapidly in recent years, increasing consumer demand for food systems to support their health and well-being.

Growing Need for Clinical Nutrition in Geriatric Population

Worldwide, the rapidly growing geriatric population has witnessed the significant impact of severe health conditions. The growing geriatric population is a major contributor to clinical nutrition market growth. Many regions are experiencing growth in their elderly population, which is highly susceptible to chronic diseases that demand clinical nutrition products during hospitalization and home care. Furthermore, the significant prevalence of severe health conditions and the demand for healthcare that often comes with aging means medical nutrition has a huge role in meeting the nutrient requirements of seniors. Medical nutrition solutions are used in and outside health settings to support surgery recovery, loss of bone and muscle, nutrient malabsorption common with aging, and many other conditions. In the APAC region, the growing aging population and expanding health facilities indicate a strong future for the clinical nutrition industry.

Growing R&D for New Compounds and Elements in Clinical Nutrition

The clinical nutrition field is continuously evolving new compounds and elements. The constant development of new compounds and elements delivers lucrative opportunities for patient care and the evolution of new clinical nutrition products. Some new and developed compounds have become more popular in recent years due to advances in supplementation, new formulations, and research in the field. Trace elements (TE) used in parenteral nutrition products are becoming popular due to advances and increasing research and development activities. Previously, multi-trace elements were poorly appreciated and not subjected to thorough oversight by the US Food & Drug Administration (FDA). After ASPEN issued the dosage for parenteral nutrition, trace elements witnessed various developments. Now, trace elements are becoming an essential part of medical nutrition. Further, one of the leading companies in the clinical nutrition industry stated that trends underway in medical nutrition include applying some specific amino acids to support patients with malnutrition and muscle loss. For example, new science-based applications are also showing up, such as Nestle's post-surgery oral impact powder, which includes Omega-3s, nucleotides, and arginine (amino acid) for immune support.

SEGMENTATION INSIGHTS

INSIGHTS BY ROUTE OF ADMINISTRATION

The global clinical nutrition market by route of administration is segmented into oral, enteral, and parenteral. In 2023, the oral segment accounted for more than 60% of the market share and dominated the other segments. The oral route of administration is easy and reliable, giving more clinical nutrition product deliveries and contributing to a significant market share. Oral nutrition support products offer additional nutrients, including energy and protein, for people and patients who cannot achieve nutritional requirements through food alone. Further, vendors' continuous development of oral clinical nutrition products, such as product form, is accelerating segmental growth.

Segmentation by Route of Administration

Oral
Enteral
Parenteral

INSIGHTS BY PRODUCT FORM

The powder products form segment accounted for the most substantial share of the global clinical nutrition market in 2023. Powder-form products are most reliable in clinical nutrition deliveries across all age groups and populations. The powder form is observing a high intake among children and adults as it reduces the complications related to swallowing. Most standard clinical nutrition products are powder-based as they satisfy micronutrient and macronutrient requirements. Powder forms are also preferred as they have extended shelf life, offer superior stability during processing, and are easy to handle, transport, and store. Such factors make powder from clinical nutrition more popular.

Segmentation by Product Form

Powder
Liquid
Semi-Solid

INSIGHTS BY AGE GROUP

The global clinical nutrition market by age group is segmented into child & teenager, infant & toddler, adult, and geriatric. In 2023, the child and teenager segment accounted for the largest segmental share. The higher burden of malnutrition and nutritional deficiency among children and the teenage population accelerates the higher segmental growth. Globally, over 100 million children under age 1 to 5 are undernourished, which offers a broad targeted patient population for market growth. On the other hand, the infant & toddler segment accounts for a second higher market share; the rapidly increasing burden of the preterm birth rate worldwide demands clinical nutrition supplies among infants and toddlers.

Segmentation by Age Group

Child & Teenager
Infant & Toddler
Adult
Geriatric

INSIGHTS BY APPLICATION

The global clinical nutrition market by application is segmented into malnutrition, metabolic disease, gastrointestinal diseases, cancer, and others. The malnutrition segment dominated the segmental share and is projected to grow at a CAGR of over 6% during the forecast period. The rising prevalence of malnutrition, metabolic disorders, GI disorders, cancer, and others accelerates the disease-associated malnutrition prevalence and drives demand for clinical nutrition support from health settings. Also, factors associated with hospitalized patients, such as age, comorbidities, and intensity of care, increase the prevalence of hospitalized malnutrition. Globally, it represents a heavy healthcare burden. Thus, advances in clinical nutrition achieved significant space for hospitalized malnutrition and fueled market growth. Furthermore, during the forecast period, the cancer application segment is expected to grow with a higher CAGR in the clinical nutrition industry.

Segmentation by Application

Malnutrition
Metabolic Disease
Gastrointestinal Diseases
Cancer
Others

INSIGHTS BY DISTRIBUTION CHANNELS

The institutional sales distribution channels hold the most significant share of the global clinical nutrition market in 2023. The significant deliveries of clinical nutrition solutions directly by the organization, such as institutional sales channels, significantly accelerated segmental growth. Institutional sales channels are operated with/by vendors, eliminating the third-party seller's involvement and reducing the extra cost burden of consumers. Institutional sales channels are responsible for covering and handling all major clients and associated marketing and sales activities, as well as directly handling healthcare settings for clinical nutritional products.

Segmentation by Distributional Channels

Institutional Sale Channels
Pharmacies & Drug Stores
Supermarkets & Hypermarkets
Online Sales Channels
Specialty Stores
Other Distribution Channels

INSIGHTS BY END-USERS

The global clinical nutrition market by end-users is segmented into hospitals, individuals, home care, and long-term care centers. The hospital's segment accounted for the largest global market share in 2023. The high hospitalization rate and hospital-associated malnutrition are the major factors that drive the high demand for clinical nutrition solutions in hospitals and fuel segmental growth. The shift of healthcare delivery from hospitals to homecare and individual care approaches is expected to drive the other segmental growth. Homecare has been a rapidly growing segment in developed markets in recent years. The availability and support of home clinical nutrition deliveries are expected to propel significant segmental growth in the future.

Segmentation by End-users

Hospitals
Individuals
Homecare
Long-term Care Centers

GEOGRAPHICAL ANALYSIS

APAC holds the largest global clinical nutrition market share, accounting for a global revenue share of over 48% in 2023. The increasing rate of preterm birth rate, the significant burden of malnutrition among children, teenagers, and adults, as well as the geriatric population, are significantly driving the demand for clinical nutrition products in APAC countries. Further, in APAC, the initiatives, support, and healthcare programs to improve the regional health index are propelling the market growth in the region. Conversely, North America is the second leading destination for the clinical nutrition market. The increasing geriatric population in the region and high demand for healthcare services across the region drive the hospitalization rate, which leads to malnutrition and the highly targeted population, such as chronically ill and hospitalized patients, thereby driving the high demand for clinical nutrition. Also, the majority of clinical nutrition industry players are present in the U.S., and the higher expenditure on healthcare and awareness about nutritional products are some of the leading factors that boost the market growth in the region.

Segmentation by Geography

APAC
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
North America
- US
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Poland
Latin America
- Brazil
- Mexico
- Argentina
Middle East & Africa
- Turkey
- Saudi Arabia
- South Africa
- Egypt

VENDOR LANDSCAPE

The global clinical nutrition market is highly competitive and has a broad range of key competitors' presence from domestic and international markets. Some emerging and new market players create higher competition. Major market players followed mergers and acquisitions, collaborative actions, product launches, market expansion, product promotions, and programs that positively influenced the competitive rivalry across the global market landscape. On the other hand, emerging market players and new start-ups are trying to achieve a solid customer base and market expansion. Also, the presence of emerging market players positively influences the competition in the industry. The primary competition among the market players accounted for new product launches, emerging, and gold standard formulations.

Abbott, B. Braun SE, Baxter, Danone, Fresenius Kabi AG, Nestle, Perrigo Company plc, and Reckitt Benckiser Group PLC are the leading market players in the global clinical nutrition market. Abbott is a leading clinical nutrition industry player and operates in the adult and pediatric nutrition business segments. The company's brand- Ensure nutrition products portfolio delivers high revenue growth to the adult nutrition business segment. In the nutrition business segment, new flavors and formulations, such as Ensure, Glucerna, Pedialyte, PediaSure, and Similac, include around 360 total care formulas offered by the company.

Key Company Profiles

Abbott
B. Braun SE
Baxter
Danone
Fresenius Kabi AG
Nestle
Perrigo Company plc
Reckitt Benckiser Group PLC

Other Prominent Vendors

ADM
Ajinomoto Co., Inc.
Aculife
Albert David
Amanta Healthcare
American Regent
BML PARENTERAL DRUGS
BASF SE
Caritas Healthcare
DSM
Eurofarma
Farmoterapica
Grifols, S.A.
Glanbia PLC
Hero Nutritionals
HUM Nutrition
ICU Medical
JW Pharmaceutical
Kelun (Sichuan Kelun Pharmaceutical)
Kendal Nutricare Limited
Lonza
Lactalis Nutrition Sante
Mend
Medifood
SternLife GmbH & Co. KG
Otsuka Holdings Co. Ltd.
Pfizer
Primus Pharmaceuticals
Soleo Health
REVIV
The Kraft Heinz Company
Vivante Health
Vifor Pharma Management

KEY QUESTIONS ANSWERED.

1. What is the growth rate of the global clinical nutrition market?

2. How big is the clinical nutrition market?

3. What are the significant trends in the clinical nutrition industry?

4. Which region dominates the global clinical nutrition market share?

5. Who are the key players in the global clinical nutrition market?

Product Code: ARZ240521

1 SCOPE & COVERAGE

1.1 MARKET DEFINITION
- 1.1.1 INCLUSIONS
- 1.1.2 EXCLUSIONS
- 1.1.3 MARKET ESTIMATION CAVEATS
1.2 MARKET SEGMENTATION
- 1.2.1 MARKET BY ROUTE OF ADMINISTRATION
- 1.2.2 MARKET BY PRODUCT FORM
- 1.2.3 MARKET BY AGE GROUP
- 1.2.4 MARKET BY APPLICATION
- 1.2.5 MARKET BY DISTRIBUTION CHANNELS
- 1.2.6 MARKET BY END-USERS
- 1.2.7 REGIONS & COUNTRIES COVERED
1.3 MARKET DERIVATION
- 1.3.1 HISTORIC, BASE, & FORECAST YEAR

2 PREMIUM INSIGHTS

2.1 OPPORTUNITY POCKETS
2.2 MARKET MATURITY NDICATOR
2.3 VENDOR SPECTRUM
2.4 REGIONAL OUTLOOK
2.5 OVERVIEW
- 2.5.1 TRENDS & OPPORTUNITIES
- 2.5.2 MARKET DRIVERS
2.6 MARKET SEGMENTATION

3 MARKET AT A GLANCE

4 INTRODUCTION

4.1 OVERVIEW
4.2 COVID-19 IMPACT ON GLOBAL CLINICAL NUTRITION MARKET
- 4.2.1 MAJOR IMPACTS OF COVID-19 ON CLINICAL NUTRITION REQUIREMENTS

5 MARKET OPPORTUNITIES & TRENDS

5.1 RISE OF TARGETED & PERSONALIZED NUTRITION
5.2 GROWING R&D FOR NEW COMPOUNDS AND ELEMENTS IN CLINICAL NUTRITION
5.3 ADVANCES IN ENTERAL CLINICAL NUTRITION
5.4 NUTRITIONAL MANAGEMENT SHIFTING TOWARD HOMECARE

6 MARKET GROWTH ENABLERS

6.1 CONSTANT INCREASING POTENTIAL PATIENT POPULATION
6.2 INCREASING BURDEN OF MALNUTRITION
6.3 GROWING NEED FOR CLINICAL NUTRITION IN GERIATRIC POPULATION

7 MARKET RESTRAINTS

7.1 STRINGENT REGULATORY NORMS
7.2 COMPLICATION ASSOCIATED WITH CLINICAL NUTRITION DELIVERY
7.3 IRREGULAR REIMBURSEMENT COVERAGE

8 MARKET LANDSCAPE

8.1 MARKET OVERVIEW
- 8.1.1 ROUTE OF ADMINISTRATION SEGMENTATION INSIGHTS
- 8.1.2 PRODUCT FORM SEGMENTATION INSIGHTS
- 8.1.3 AGE GROUP SEGMENTATION INSIGHTS
- 8.1.4 APPLICATION SEGMENTATION INSIGHTS
- 8.1.5 DISTRIBUTION CHANNEL SEGMENTATION INSIGHTS
- 8.1.6 END-USERS SEGMENTATION INSIGHTS
- 8.1.7 GEOGRAPHY SEGMENTATION INSIGHTS
8.2 MARKET SIZE & FORECAST
8.3 FIVE FORCES ANALYSIS
- 8.3.1 THREAT OF NEW ENTRANTS
- 8.3.2 BARGAINING POWER OF SUPPLIERS
- 8.3.3 BARGAINING POWER OF BUYERS
- 8.3.4 THREAT OF SUBSTITUTES
- 8.3.5 COMPETITIVE RIVALRY

9 ROUTE OF ADMINISTRATION

9.1 MARKET SNAPSHOT & GROWTH ENGINE
9.2 MARKET OVERVIEW
9.3 ORAL
- 9.3.1 MARKET OVERVIEW
- 9.3.2 MARKET SIZE & FORECAST
- 9.3.3 MARKET BY GEOGRAPHY
9.4 ENTERAL
- 9.4.1 MARKET OVERVIEW
- 9.4.2 MARKET SIZE & FORECAST
- 9.4.3 MARKET BY GEOGRAPHY
9.5 PARENTERAL NUTRITION
- 9.5.1 MARKET OVERVIEW
- 9.5.2 MARKET SIZE & FORECAST
- 9.5.3 MARKET BY GEOGRAPHY

10 PRODUCT FORM

10.1 MARKET SNAPSHOT & GROWTH ENGINE
10.2 MARKET OVERVIEW
10.3 POWDER
- 10.3.1 MARKET OVERVIEW
- 10.3.2 MARKET SIZE & FORECAST
- 10.3.3 MARKET BY GEOGRAPHY
10.4 LIQUID
- 10.4.1 MARKET OVERVIEW
- 10.4.2 MARKET SIZE & FORECAST
- 10.4.3 MARKET BY GEOGRAPHY
10.5 SEMI-SOLID
- 10.5.1 MARKET OVERVIEW
- 10.5.2 MARKET SIZE & FORECAST
- 10.5.3 MARKET BY GEOGRAPHY

11 AGE GROUP

11.1 MARKET SNAPSHOT & GROWTH ENGINE
11.2 MARKET OVERVIEW
11.3 CHILDREN & TEENAGER
- 11.3.1 MARKET OVERVIEW
- 11.3.2 MARKET SIZE & FORECAST
- 11.3.3 MARKET BY GEOGRAPHY
11.4 INFANT & TODDLERS
- 11.4.1 MARKET OVERVIEW
- 11.4.2 MARKET SIZE & FORECAST
- 11.4.3 MARKET BY GEOGRAPHY
11.5 ADULT
- 11.5.1 MARKET OVERVIEW
- 11.5.2 MARKET SIZE & FORECAST
- 11.5.3 MARKET BY GEOGRAPHY
11.6 GERIATRIC
- 11.6.1 MARKET OVERVIEW
- 11.6.2 MARKET SIZE & FORECAST
- 11.6.3 MARKET BY GEOGRAPHY

12 APPLICATION

12.1 MARKET SNAPSHOT & GROWTH ENGINE
12.2 MARKET OVERVIEW
12.3 MALNUTRITION
- 12.3.1 MARKET OVERVIEW
- 12.3.2 MARKET SIZE & FORECAST
- 12.3.3 MARKET BY GEOGRAPHY
12.4 METABOLIC DISEASE
- 12.4.1 MARKET OVERVIEW
- 12.4.2 MARKET SIZE & FORECAST
- 12.4.3 MARKET BY GEOGRAPHY
12.5 GASTROINTESTINAL DISEASES
- 12.5.1 MARKET OVERVIEW
- 12.5.2 MARKET SIZE & FORECAST
- 12.5.3 MARKET BY GEOGRAPHY
12.6 CANCER
- 12.6.1 MARKET OVERVIEW
- 12.6.2 MARKET SIZE & FORECAST
- 12.6.3 MARKET BY GEOGRAPHY
12.7 OTHERS
- 12.7.1 MARKET OVERVIEW
- 12.7.2 MARKET SIZE & FORECAST
- 12.7.3 MARKET BY GEOGRAPHY

13 DISTRIBUTION CHANNELS

13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 INSTITUTIONAL SALE CHANNELS
- 13.3.1 MARKET OVERVIEW
- 13.3.2 MARKET SIZE & FORECAST
- 13.3.3 MARKET BY GEOGRAPHY
13.4 PHARMACIES & DRUG STORES
- 13.4.1 MARKET OVERVIEW
- 13.4.2 MARKET SIZE & FORECAST
- 13.4.3 MARKET BY GEOGRAPHY
13.5 SUPERMARKETS & HYPERMARKETS
- 13.5.1 MARKET OVERVIEW
- 13.5.2 MARKET SIZE & FORECAST
- 13.5.3 MARKET BY GEOGRAPHY
13.6 ONLINE SALE CHANNELS
- 13.6.1 MARKET OVERVIEW
- 13.6.2 MARKET SIZE & FORECAST
- 13.6.3 MARKET BY GEOGRAPHY
13.7 SPECIALTY STORES
- 13.7.1 MARKET OVERVIEW
- 13.7.2 MARKET SIZE & FORECAST
- 13.7.3 MARKET BY GEOGRAPHY
13.8 OTHER DISTRIBUTION CHANNELS
- 13.8.1 MARKET OVERVIEW
- 13.8.2 MARKET SIZE & FORECAST
- 13.8.3 MARKET BY GEOGRAPHY

14 END-USERS

14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 HOSPITALS
- 14.3.1 MARKET OVERVIEW
- 14.3.2 MARKET SIZE & FORECAST
- 14.3.3 MARKET BY GEOGRAPHY
14.4 INDIVIDUAL
- 14.4.1 MARKET OVERVIEW
- 14.4.2 MARKET SIZE & FORECAST
- 14.4.3 MARKET BY GEOGRAPHY
14.5 HOMECARE
- 14.5.1 MARKET OVERVIEW
- 14.5.2 MARKET SIZE & FORECAST
- 14.5.3 MARKET BY GEOGRAPHY
14.6 LONG-TERM CARE CENTERS
- 14.6.1 MARKET OVERVIEW
- 14.6.2 MARKET SIZE & FORECAST
- 14.6.3 MARKET BY GEOGRAPHY

15 GEOGRAPHY

15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 GEOGRAPHIC OVERVIEW

16 APAC

16.1 MARKET OVERVIEW
16.2 MARKET SIZE & FORECAST
16.3 ROUTE OF ADMINISTRATION
- 16.3.1 MARKET SIZE & FORECAST
16.4 PRODUCT FORM
- 16.4.1 MARKET SIZE & FORECAST
16.5 AGE GROUP
- 16.5.1 MARKET SIZE & FORECAST
16.6 APPLICATION
- 16.6.1 MARKET SIZE & FORECAST
16.7 DISTRIBUTION CHANNELS
- 16.7.1 MARKET SIZE & FORECAST
16.8 END-USERS
- 16.8.1 MARKET SIZE & FORECAST
16.9 KEY COUNTRIES
16.10 CHINA: MARKET SIZE & FORECAST
16.11 JAPAN: MARKET SIZE & FORECAST
16.12 INDIA: MARKET SIZE & FORECAST
16.13 SOUTH KOREA: MARKET SIZE & FORECAST
16.14 AUSTRALIA: MARKET SIZE & FORECAST
16.15 INDONESIA: MARKET SIZE & FORECAST

17 NORTH AMERICA

17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 ROUTE OF ADMINISTRATION
- 17.3.1 MARKET SIZE & FORECAST
17.4 PRODUCT FORM
- 17.4.1 MARKET SIZE & FORECAST
17.5 AGE GROUP
- 17.5.1 MARKET SIZE & FORECAST
17.6 APPLICATION
- 17.6.1 MARKET SIZE & FORECAST
17.7 DISTRIBUTION CHANNELS
- 17.7.1 MARKET SIZE & FORECAST
17.8 END-USERS
- 17.8.1 MARKET SIZE & FORECAST
17.9 KEY COUNTRIES
17.10 US: MARKET SIZE & FORECAST
17.11 CANADA: MARKET SIZE & FORECAST

18 EUROPE

18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 ROUTE OF ADMINISTRATION
- 18.3.1 MARKET SIZE & FORECAST
18.4 PRODUCT FORM
- 18.4.1 MARKET SIZE & FORECAST
18.5 AGE GROUP
- 18.5.1 MARKET SIZE & FORECAST
18.6 APPLICATION
- 18.6.1 MARKET SIZE & FORECAST
18.7 DISTRIBUTION CHANNELS
- 18.7.1 MARKET SIZE & FORECAST
18.8 END-USERS
- 18.8.1 MARKET SIZE & FORECAST
18.9 KEY COUNTRIES
18.10 GERMANY: MARKET SIZE & FORECAST
18.11 UK: MARKET SIZE & FORECAST
18.12 FRANCE: MARKET SIZE & FORECAST
18.13 ITALY: MARKET SIZE & FORECAST
18.14 SPAIN: MARKET SIZE & FORECAST
18.15 RUSSIA: MARKET SIZE & FORECAST
18.16 POLAND: MARKET SIZE & FORECAST

19 LATIN AMERICA

19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 ROUTE OF ADMINISTRATION
- 19.3.1 MARKET SIZE & FORECAST
19.4 PRODUCT FORM
- 19.4.1 MARKET SIZE & FORECAST
19.5 AGE GROUP
- 19.5.1 MARKET SIZE & FORECAST
19.6 APPLICATION
- 19.6.1 MARKET SIZE & FORECAST
19.7 DISTRIBUTION CHANNELS
- 19.7.1 MARKET SIZE & FORECAST
19.8 END-USERS
- 19.8.1 MARKET SIZE & FORECAST
19.9 KEY COUNTRIES
19.10 BRAZIL: MARKET SIZE & FORECAST
19.11 MEXICO: MARKET SIZE & FORECAST
19.12 ARGENTINA: MARKET SIZE & FORECAST

20 MIDDLE EAST & AFRICA

20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 ROUTE OF ADMINISTRATION
- 20.3.1 MARKET SIZE & FORECAST
20.4 PRODUCT FORM
- 20.4.1 MARKET SIZE & FORECAST
20.5 AGE GROUP
- 20.5.1 MARKET SIZE & FORECAST
20.6 APPLICATION
- 20.6.1 MARKET SIZE & FORECAST
20.7 DISTRIBUTION CHANNELS
- 20.7.1 MARKET SIZE & FORECAST
20.8 END-USERS
- 20.8.1 MARKET SIZE & FORECAST
20.9 KEY COUNTRIES
20.10 TURKEY: MARKET SIZE & FORECAST
20.11 SAUDI ARABIA: MARKET SIZE & FORECAST
20.12 SOUTH AFRICA: MARKET SIZE & FORECAST
20.13 EGYPT: MARKET SIZE & FORECAST

21 COMPETITIVE LANDSCAPE

21.1 COMPETITION OVERVIEW
21.2 MARKET SHARE ANALYSIS
- 21.2.1 ABBOTT
- 21.2.2 B. BRAUN
- 21.2.3 BAXTER
- 21.2.4 DANONE
- 21.2.5 FRESENIUS KABI AG
- 21.2.6 NESTLE
- 21.2.7 PERRIGO COMPANY PLC
- 21.2.8 RECKITT BENCKISER GROUP

22 KEY COMPANY PROFILES

22.1 ABBOTT
- 22.1.1 BUSINESS OVERVIEW
- 22.1.2 PRODUCT OFFERINGS
- 22.1.3 KEY STRATEGIES
- 22.1.4 KEY STRENGTHS
- 22.1.5 KEY OPPORTUNITIES
22.2 B. BRAUN SE
- 22.2.1 BUSINESS OVERVIEW
- 22.2.2 PRODUCT OFFERINGS
- 22.2.3 KEY STRATEGIES
- 22.2.4 KEY STRENGTHS
- 22.2.5 KEY OPPORTUNITIES
22.3 BAXTER
- 22.3.1 BUSINESS OVERVIEW
- 22.3.2 PRODUCT OFFERINGS
- 22.3.3 KEY STRATEGIES
- 22.3.4 KEY STRENGTHS
- 22.3.5 KEY OPPORTUNITIES
22.4 DANONE
- 22.4.1 BUSINESS OVERVIEW
- 22.4.2 PRODUCT OFFERINGS
- 22.4.3 KEY STRATEGIES
- 22.4.4 KEY STRENGTHS
- 22.4.5 KEY OPPORTUNITIES
22.5 FRESENIUS KABI AG
- 22.5.1 BUSINESS OVERVIEW
- 22.5.2 PRODUCT OFFERINGS
- 22.5.3 KEY STRATEGIES
- 22.5.4 KEY STRENGTHS
- 22.5.5 KEY OPPORTUNITIES
22.6 NESTLE
- 22.6.1 BUSINESS OVERVIEW
- 22.6.2 PRODUCT OFFERINGS
- 22.6.3 KEY STRATEGIES
- 22.6.4 KEY STRENGTHS
- 22.6.5 KEY OPPORTUNITIES
22.7 PERRIGO COMPANY PLC
- 22.7.1 BUSINESS OVERVIEW
- 22.7.2 PRODUCT OFFERINGS
- 22.7.3 KEY STRATEGIES
- 22.7.4 KEY STRENGTHS
- 22.7.5 KEY OPPORTUNITIES
22.8 RECKITT BENCKISER GROUP PLC
- 22.8.1 BUSINESS OVERVIEW
- 22.8.2 PRODUCT OFFERINGS
- 22.8.3 KEY STRATEGIES
- 22.8.4 KEY STRENGTHS
- 22.8.5 KEY OPPORTUNITIES

23 OTHER PROMINENT VENDORS

23.1 ADM
- 23.1.1 BUSINESS OVERVIEW
- 23.1.2 PRODUCT OFFERINGS
23.2 AJINOMOTO CO., INC.
- 23.2.1 BUSINESS OVERVIEW
- 23.2.2 PRODUCT OFFERINGS
23.3 ACULIFE
- 23.3.1 BUSINESS OVERVIEW
- 23.3.2 PRODUCT OFFERINGS
23.4 ALBERT DAVID
- 23.4.1 BUSINESS OVERVIEW
- 23.4.2 PRODUCT OFFERINGS
23.5 AMANTA HEALTHCARE
- 23.5.1 BUSINESS OVERVIEW
- 23.5.2 PRODUCT OFFERINGS
23.6 AMERICAN REGENT
- 23.6.1 BUSINESS OVERVIEW
- 23.6.2 PRODUCT OFFERINGS
23.7 BML PARENTERAL DRUGS
- 23.7.1 BUSINESS OVERVIEW
- 23.7.2 PRODUCT OFFERINGS
23.8 BASF SE
- 23.8.1 BUSINESS OVERVIEW
- 23.8.2 PRODUCT OFFERINGS
23.9 CARITAS HEALTHCARE
- 23.9.1 BUSINESS OVERVIEW
- 23.9.2 PRODUCT OFFERINGS
23.10 CSL VIFOR
- 23.10.1 BUSINESS OVERVIEW
- 23.10.2 PRODUCT OFFERINGS
23.11 DSM
- 23.11.1 BUSINESS OVERVIEW
- 23.11.2 PRODUCT OFFERINGS
23.12 EUROFARMA
- 23.12.1 BUSINESS OVERVIEW
- 23.12.2 PRODUCT OFFERINGS
23.13 FARMOTERAPICA
- 23.13.1 BUSINESS OVERVIEW
- 23.13.2 PRODUCT OFFERINGS
23.14 GRIFOLS, S.A.
- 23.14.1 BUSINESS OVERVIEW
- 23.14.2 PRODUCT OFFERINGS
23.15 GLANBIA PLC
- 23.15.1 BUSINESS OVERVIEW
- 23.15.2 PRODUCT OFFERINGS
23.16 HERO NUTRITIONALS
- 23.16.1 BUSINESS OVERVIEW
- 23.16.2 PRODUCT OFFERINGS
23.17 HUM NUTRITION
- 23.17.1 BUSINESS OVERVIEW
- 23.17.2 PRODUCT OFFERINGS
23.18 ICU MEDICAL
- 23.18.1 BUSINESS OVERVIEW
- 23.18.2 PRODUCT OFFERINGS
23.19 JW PHARMACEUTICAL
- 23.19.1 BUSINESS OVERVIEW
- 23.19.2 PRODUCT OFFERINGS
23.20 KELUN (SICHUAN KELUN PHARMACEUTICALS)
- 23.20.1 BUSINESS OVERVIEW
- 23.20.2 PRODUCT OFFERINGS
23.21 KENDAL NUTRICARE LIMITED
- 23.21.1 BUSINESS OVERVIEW
- 23.21.2 PRODUCT OFFERINGS
23.22 LONZA
- 23.22.1 BUSINESS OVERVIEW
- 23.22.2 PRODUCT OFFERINGS
23.23 MEND
- 23.23.1 BUSINESS OVERVIEW
- 23.23.2 PRODUCT OFFERINGS
23.24 MEDIFOOD
- 23.24.1 BUSINESS OVERVIEW
- 23.24.2 PRODUCT OFFERINGS
23.25 STERNLIFE GMBH & CO. KG
- 23.25.1 BUSINESS OVERVIEW
- 23.25.2 PRODUCT OFFERINGS
23.26 OTSUKA HOLDINGS CO. LTD.
- 23.26.1 BUSINESS OVERVIEW
- 23.26.2 PRODUCT OFFERINGS
23.27 PFIZER
- 23.27.1 BUSINESS OVERVIEW
- 23.27.2 PRODUCT OFFERINGS
23.28 PRIMUS PHARMACEUTICALS
- 23.28.1 BUSINESS OVERVIEW
- 23.28.2 PRODUCT OFFERINGS
23.29 REVIV
- 23.29.1 BUSINESS OVERVIEW
- 23.29.2 PRODUCT OFFERINGS
23.30 SOLEO HEALTH
- 23.30.1 BUSINESS OVERVIEW
- 23.30.2 PRODUCT OFFERINGS
23.31 SOLACE NUTRITION
- 23.31.1 BUSINESS OVERVIEW
- 23.31.2 PRODUCT OFFERINGS
23.32 THE KRAFT HEINZ COMPANY
- 23.32.1 BUSINESS OVERVIEW
- 23.32.2 PRODUCT OFFERINGS

24 REPORT SUMMARY

24.1 KEY TAKEAWAYS
24.2 STRATEGIC RECOMMENDATIONS

25 QUANTITATIVE SUMMARY

25.1 MARKET BY GEOGRAPHY
25.2 MARKET BY ROUTE OF ADMINISTRATION
25.3 MARKET BY PRODUCT FORM
25.4 MARKET BY AGE GROUP
25.5 MARKET BY APPLICATION
25.6 MARKET BY DISTRIBUTION CHANNELS
25.7 MARKET BY END-USERS
25.8 ROUTE OF ADMINISTRATION: MARKET BY GEOGRAPHY
- 25.8.1 ORAL
- 25.8.2 ENTERAL
- 25.8.3 PARENTERAL
25.9 PRODUCT FORM: MARKET BY GEOGRAPHY
- 25.9.1 POWDER
- 25.9.2 LIQUID
- 25.9.3 SEMI-SOLID
25.10 AGE GROUP: MARKET BY GEOGRAPHY
- 25.10.1 CHILDREN & TEENAGERS
- 25.10.2 INFANTS & TODDLERS
- 25.10.3 ADULTS
- 25.10.4 GERIATRIC
25.11 APPLICATION: MARKET BY GEOGRAPHY
- 25.11.1 MALNUTRITION
- 25.11.2 METABOLIC DISORDERS
- 25.11.3 GASTROINTESTINAL DISORDERS
- 25.11.4 CANCER
- 25.11.5 OTHER APPLICATIONS
25.12 DISTRIBUTION CHANNELS: MARKET BY GEOGRAPHY
- 25.12.1 INSTITUTIONAL SALES CHANNELS
- 25.12.2 PHARMACIES & DRUG STORES
- 25.12.3 SUPERMARKETS & HYPERMARKETS
- 25.12.4 ONLINE SALES CHANNELS
- 25.12.5 SPECIALTY STORES
- 25.12.6 OTHER DISTRIBUTION CHANNELS
25.13 END-USERS: MARKET BY GEOGRAPHY
- 25.13.1 HOSPITALS
- 25.13.2 INDIVIDUALS
- 25.13.3 HOMECARE
- 25.13.4 LTC

26 APPENDIX

26.1 RESEARCH METHODOLOGY
26.2 RESEARCH PROCESS
26.3 REPORT ASSUMPTIONS & CAVEATS
- 26.3.1 KEY CAVEATS
- 26.3.2 CURRENCY CONVERSION
26.4 ABBREVIATIONS